Literature DB >> 20714753

Neurological involvement in a child with atypical hemolytic uremic syndrome.

Bérengère Koehl1, Olivia Boyer, Nathalie Biebuyck-Gougé, Manoelle Kossorotoff, Véronique Frémeaux-Bacchi, Nathalie Boddaert, Patrick Niaudet.   

Abstract

We report the case of a 4-year-old boy, diagnosed with atypical hemolytic uremic syndrome (HUS) due to a hybrid factor H. He progressed to end-stage renal failure despite plasmatherapy and underwent bilateral nephrectomy because of uncontrolled hypertension. Three days after, he had partial complex seizures with normal blood pressure, normal blood count and normal magnetic resonance imaging (MRI), which recurred 1 month later. Eight months later, he had a third episode of seizures, with hemoglobin of 10 g/dl without schizocytes, low haptoglobin of 0.18 g/l, and moderate thrombocytopenia (platelets 98 × 10(9)/l). He remained hypertensive and deeply confused for 2 days. The third MRI showed bilateral symmetrical hyperintensities of the cerebral pedunculas, caudate nuclei, putamens, thalami, hippocampi, and insulae suggesting thrombotic microangiopathy secondary to a relapse of HUS rather than reversible posterior leukoencephalopathy syndrome (RPLS), usually occipital and asymmetrical. Plasmatherapy led to a complete neurological recovery within 2 days although hypertension had remained uncontrolled. The fourth MRI 10 weeks after, on maintenance plasmatherapy, was normal and clinical examination remained normal, except for high blood pressure. In conclusion, brain MRI allows differentiating thrombotic microangiopathy lesions from RPLS in atypical HUS, which is crucial since lesions may be reversible with plasmatherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714753     DOI: 10.1007/s00467-010-1606-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Localization of verotoxin receptors in nervous system.

Authors:  J Ren; I Utsunomiya; K Taguchi; T Ariga; T Tai; Y Ihara; T Miyatake
Journal:  Brain Res       Date:  1999-04-17       Impact factor: 3.252

2.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Central nervous system involvement in a child with hemolytic uremic syndrome.

Authors:  E Signorini; S Lucchi; M Mastrangelo; S Rapuzzi; A Edefonti; E Fossali
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

4.  Central nervous system involvement in hemolytic uremic syndrome (HUS)--a retrospective analysis of cerebral CT and MRI studies.

Authors:  I Theobald; E Kuwertz-Bröking; M Schiborr; W Heindel
Journal:  Clin Nephrol       Date:  2001-12       Impact factor: 0.975

5.  MRI findings of hemolytic uremic syndrome with encephalopathy: widespread symmetrical distribution.

Authors:  Hiroshi Nakamura; Hitonori Takaba; Takeshi Inoue; Yoshisuke Saku; Fumihiko Saito; Setsuro Ibayashi; Masatoshi Fujishima
Journal:  J Neuroimaging       Date:  2003-01       Impact factor: 2.486

6.  CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Authors:  Marc Steinborn; Steffen Leiz; Klaus Rüdisser; Martin Griebel; Thomas Harder; Helmut Hahn
Journal:  Pediatr Radiol       Date:  2004-07-29

7.  Lacunar infarction of the basal ganglia as a complication of hemolytic-uremic syndrome. MRI and clinical correlations.

Authors:  F J DiMario; H Brönte-Stewart; J Sherbotie; M E Turner
Journal:  Clin Pediatr (Phila)       Date:  1987-11       Impact factor: 1.168

8.  Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy.

Authors:  H Ogura; M Takaoka; M Kishi; M Kimoto; T Shimazu; T Yoshioka; H Sugimoto
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

9.  Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.

Authors:  Julian P Venables; Lisa Strain; Danny Routledge; David Bourn; Helen M Powell; Paul Warwicker; Martha L Diaz-Torres; Anne Sampson; Paul Mead; Michelle Webb; Yves Pirson; Michael S Jackson; Anne Hughes; Katrina M Wood; Judith A Goodship; Timothy H J Goodship
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

10.  Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.

Authors:  Kiyomi Takahashi; Nobuaki Funata; Fusahiro Ikuta; Shigehiro Sato
Journal:  J Neuroinflammation       Date:  2008-03-21       Impact factor: 8.322

View more
  18 in total

1.  Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Authors:  Elena Bresin; Erica Rurali; Jessica Caprioli; Pilar Sanchez-Corral; Veronique Fremeaux-Bacchi; Santiago Rodriguez de Cordoba; Sheila Pinto; Timothy H J Goodship; Marta Alberti; David Ribes; Elisabetta Valoti; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

2.  Macrovascular involvement in a child with atypical hemolytic uremic syndrome.

Authors:  Karolis Ažukaitis; Chantal Loirat; Michal Malina; Irina Adomaitienė; Augustina Jankauskienė
Journal:  Pediatr Nephrol       Date:  2013-12-19       Impact factor: 3.714

Review 3.  Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Nephrol       Date:  2013-08-06

4.  Success of eculizumab in the treatment of atypical hemolytic uremic syndrome.

Authors:  Esra Baskin; Kaan Gulleroglu; Asli Kantar; Umut Bayrakci; Ozan Ozkaya
Journal:  Pediatr Nephrol       Date:  2014-11-11       Impact factor: 3.714

5.  Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.

Authors:  Kaan Gulleroglu; Kibriya Fidan; Veysel S Hançer; Umut Bayrakci; Esra Baskin; Oguz Soylemezoglu
Journal:  Pediatr Nephrol       Date:  2013-02-07       Impact factor: 3.714

6.  Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.

Authors:  Kibriya Fidan; Nilüfer Göknar; Bora Gülhan; Engin Melek; Zeynep Y Yıldırım; Esra Baskın; Mutlu Hayran; Kaan Gülleroglu; Zeynep B Özçakar; Fatih Ozaltin; Oguz Soylemezoglu
Journal:  Pediatr Nephrol       Date:  2018-04-02       Impact factor: 3.714

7.  Central nervous system involvement in adults with epidemic hemolytic uremic syndrome.

Authors:  M Wengenroth; J Hoeltje; J Repenthin; T N Meyer; F Bonk; H Becker; S Faiss; O Stammel; P P Urban; R Bruening
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

Review 8.  Extra-renal manifestations of atypical hemolytic uremic syndrome.

Authors:  Cassandra Formeck; Agnieszka Swiatecka-Urban
Journal:  Pediatr Nephrol       Date:  2018-08-14       Impact factor: 3.714

9.  Neurological manifestations of thrombotic microangiopathy syndromes in adult patients.

Authors:  Erika L Weil; Alejandro A Rabinstein
Journal:  J Thromb Thrombolysis       Date:  2021-03-23       Impact factor: 2.300

Review 10.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.